BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 3865011)

  • 1. Evaluation of the effects of cotinine and nicotine-N'-oxides on the development of tumors in rats initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    LaVoie EJ; Shigematsu A; Rivenson A; Mu B; Hoffmann D
    J Natl Cancer Inst; 1985 Dec; 75(6):1075-81. PubMed ID: 3865011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term studies on the in vivo metabolism of N-oxides of nicotine in rats.
    Sepkovic DW; Haley NJ; Axelrad CM; Shigematsu A; LaVoie EJ
    J Toxicol Environ Health; 1986; 18(2):205-14. PubMed ID: 3712485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sodium phenobarbital and sodium saccharin in AIN-76A diet on carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and N,N-dibutylnitrosamine in male F344 rats.
    Imaida K; Wang CY
    Cancer Res; 1986 Dec; 46(12 Pt 1):6160-4. PubMed ID: 3779637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats.
    Sakata T; Hasegawa R; Johansson SL; Zenser TV; Cohen SM
    Cancer Res; 1986 Aug; 46(8):3903-6. PubMed ID: 3731063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of L-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Fukushima S; Friedell GH; Jacobs JB; Cohen SM
    Cancer Res; 1981 Aug; 41(8):3100-3. PubMed ID: 7248968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative bladder tumor promoting activity of sodium saccharin, sodium ascorbate, related acids, and calcium salts in rats.
    Cohen SM; Ellwein LB; Okamura T; Masui T; Johansson SL; Smith RA; Wehner JM; Khachab M; Chappel CI; Schoenig GP
    Cancer Res; 1991 Apr; 51(7):1766-77. PubMed ID: 2004360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Cohen SM; Hasegawa R; Sakata T; Johansson SL
    Cancer Res; 1989 Jan; 49(2):372-7. PubMed ID: 2491954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of L-tryptophan excess and vitamin B6 deficiency on rat urinary bladder cancer promotion.
    Birt DF; Julius AD; Hasegawa R; St John M; Cohen SM
    Cancer Res; 1987 Mar; 47(5):1244-50. PubMed ID: 3815336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dose on urinary bladder carcinogenesis induced in F344 rats by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Arai M; Cohen SM; Jacobs JB; Friedell GH
    J Natl Cancer Inst; 1979 Apr; 62(4):1013-6. PubMed ID: 285273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of bladder tumor promoting activity in rats fed sodium saccharin in AIN-76A diet.
    Okamura T; Garland EM; Masui T; Sakata T; St John M; Cohen SM
    Cancer Res; 1991 Apr; 51(7):1778-82. PubMed ID: 2004361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced carcinogenesis by urinary tract infection in rats.
    Johansson SL; Anderström C; von Schultz L; Larsson P
    Cancer Res; 1987 Jan; 47(2):559-62. PubMed ID: 3539325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis.
    Cohen SM; Arai M; Jacobs JB; Friedell GH
    Cancer Res; 1979 Apr; 39(4):1207-17. PubMed ID: 421204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neovascularization in rats during urinary bladder carcinogenesis induced by N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide.
    Cohen SM; Tatematsu M; Shinohara Y; Nakanishi K; Ito N
    J Natl Cancer Inst; 1980 Jul; 65(1):145-8. PubMed ID: 6930511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sodium salts of phenobarbital and barbital on development of bladder tumors in male F344/NCr rats pretreated with either N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or N-nitrosobutyl-4-hydroxybutylamine.
    Diwan BA; Hagiwara A; Ward JM; Rice JM
    Toxicol Appl Pharmacol; 1989 Apr; 98(2):269-77. PubMed ID: 2711390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of single dose N-methyl-N-nitrosourea on bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats.
    Grossman HB; Sonda LP; Lesser ML
    Invest Urol; 1981 May; 18(8):457-9. PubMed ID: 7228579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H-ras mutations in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and sodium saccharin, sodium ascorbate, or related salts.
    Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Fujii H; Pelling JC; Cohen SM
    Cancer Res; 1991 Jul; 51(13):3471-5. PubMed ID: 2054786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species variation and stereoselectivity in the metabolism of nicotine enantiomers.
    Nwosu CG; Crooks PA
    Xenobiotica; 1988 Dec; 18(12):1361-72. PubMed ID: 3245230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide.
    Cohen SM; Wittenberg JF; Bryan GT
    Cancer Res; 1976 Jul; 36(7 PT 1):2334-9. PubMed ID: 1277139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid hormone concentrations in rats after chronic nicotine metabolite administration.
    Sepkovic DW; Haley NJ; Axelrad CM; LaVoie EJ
    Proc Soc Exp Biol Med; 1984 Dec; 177(3):412-6. PubMed ID: 6514716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long-term study of reversible and progressive urinary bladder cancer lesions in rats fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Jacobs JB; Arai M; Cohen SM; Friedell GH
    Cancer Res; 1977 Aug; 37(8 Pt 2):2817-21. PubMed ID: 872108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.